Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03189108 · ClinicalTrials.gov registry record
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
A clinical trial, sponsored by National Cancer Institute (NCI).
- Terminated
- Registry status
- 22
- Enrollment target
NCT03189108: Clinical Trial study, sponsored by National Cancer Institute (NCI).
NCT03189108 is a clinical trial that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03189108 was terminated before completion, sponsored by National Cancer Institute (NCI).
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Background: Researchers want to study fluids and blood of people with cancer. The fluids are from the abdomen and around the lungs. Studying these might help researchers learn about the biology of cancer. This may lead to better ways to treat cancer. Objectives: To study the biology of cancer. Eligibility: Adults 18 and older with malignant solid tumors. Design: Participants will be screened with medical history, blood tests, and confirmation of diagnosis. Participants will have samples taken at regularly scheduled procedures. Fluids from the abdomen and/or lungs will be taken as part of the procedures. Blood will be taken separately. Participants may be asked to give more samples at future procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2023-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03189108
The ClinicalTrials.gov registry entry for NCT03189108 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03189108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03189108 about?
NCT03189108 is a clinical study titled "Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors". Background: Researchers want to study fluids and blood of people with cancer. The fluids are from the abdomen and around the lungs. Studying these might help researchers learn about the biology of cancer. This may lead to better ways to treat cancer. Objectives: To study the biology of cancer. E...
What is the current status of trial NCT03189108?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2017-05-22. Estimated completion is 2023-05-18.
Who is sponsoring clinical trial NCT03189108?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.